AbCellera Biologics Inc. ABCL Investments
Investments at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s investments?
- AbCellera Biologics Inc. (ABCL) reported investments of $65.31M in Q1 2026.
- How has AbCellera Biologics Inc.'s investments changed year-over-year?
- AbCellera Biologics Inc.'s investments decreased by 19.9% year-over-year, from $81.57M to $65.31M.
- What is the long-term trend for AbCellera Biologics Inc.'s investments?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s investments has grown at a 26.6% compound annual growth rate (CAGR), from $19.25M to $62.58M.